Bernard Moss - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Bernard Moss

Showing results (201-210 of 308) with videos related to

Pageof 31

Sort By:

Journal of Immunology (Baltimore, Md. : 1950)|December 6, 2011

Skin mast cells protect mice against vaccinia virus by triggering mast cell receptor S1PR2 and releasing antimicrobial peptidesZhenping Wang, Yuping Lai, Jamie J Bernard, et al.

Proceedings of the National Academy of Sciences of the United States of America|April 21, 2004

Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes miceHimani Bisht, Anjeanette Roberts, Leatrice Vogel, et al.

Journal of Virology|April 24, 2015

Deciphering poxvirus gene expression by RNA sequencing and ribosome profilingZhilong Yang, Shuai Cao, Craig A Martens, et al.

Virology|September 28, 2002

Expression of the vaccinia virus A2.5L redox protein is required for virion morphogenesisTatiana G Senkevich, Christine L White, Andrea Weisberg, et al.

Medrxiv : the Preprint Server for Health Sciences|September 24, 2024

Rapid Decline of Mpox Antibody Responses Following MVA-BN VaccinationAi-Ris Y Collier, Katherine McMahan, Catherine Jacob-Dolan, et al.

JAMA|October 3, 2024

Decline of Mpox Antibody Responses After Modified Vaccinia Ankara-Bavarian Nordic VaccinationAi-Ris Y Collier, Katherine McMahan, Catherine Jacob-Dolan, et al.

Virology|January 15, 2014

Susceptibility of the wild-derived inbred CAST/Ei mouse to infection by orthopoxviruses analyzed by live bioluminescence imagingJeffrey L Americo, Cindy L Sood, Catherine A Cotter, et al.

Cell Host & Microbe|August 21, 2012

Degradation of host microRNAs by poxvirus poly(A) polymerase reveals terminal RNA methylation as a protective antiviral mechanismSimone Backes, Jillian S Shapiro, Leah R Sabin, et al.

AIDS Research and Human Retroviruses|July 10, 2004

Multiprotein HIV type 1 clade B DNA and MVA vaccines: construction, expression, and immunogenicity in rodents of the MVA componentLinda S Wyatt, Patricia L Earl, Jin Yan Liu, et al.

Vaccine|December 25, 2007

Correlation of immunogenicities and in vitro expression levels of recombinant modified vaccinia virus Ankara HIV vaccinesLinda S Wyatt, Patricia L Earl, Jennifer Vogt, et al.

Pageof 31

Search research articles

Showing results (201-210 of 308) with videos related to

Sort By:

Pageof 31

Journal of Immunology (Baltimore, Md. : 1950)|December 6, 2011

Skin mast cells protect mice against vaccinia virus by triggering mast cell receptor S1PR2 and releasing antimicrobial peptidesZhenping Wang, Yuping Lai, Jamie J Bernard, et al.

Proceedings of the National Academy of Sciences of the United States of America|April 21, 2004

Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes miceHimani Bisht, Anjeanette Roberts, Leatrice Vogel, et al.

Journal of Virology|April 24, 2015

Deciphering poxvirus gene expression by RNA sequencing and ribosome profilingZhilong Yang, Shuai Cao, Craig A Martens, et al.

Virology|September 28, 2002

Expression of the vaccinia virus A2.5L redox protein is required for virion morphogenesisTatiana G Senkevich, Christine L White, Andrea Weisberg, et al.

Medrxiv : the Preprint Server for Health Sciences|September 24, 2024

Rapid Decline of Mpox Antibody Responses Following MVA-BN VaccinationAi-Ris Y Collier, Katherine McMahan, Catherine Jacob-Dolan, et al.

JAMA|October 3, 2024

Decline of Mpox Antibody Responses After Modified Vaccinia Ankara-Bavarian Nordic VaccinationAi-Ris Y Collier, Katherine McMahan, Catherine Jacob-Dolan, et al.

Virology|January 15, 2014

Susceptibility of the wild-derived inbred CAST/Ei mouse to infection by orthopoxviruses analyzed by live bioluminescence imagingJeffrey L Americo, Cindy L Sood, Catherine A Cotter, et al.

Cell Host & Microbe|August 21, 2012

Degradation of host microRNAs by poxvirus poly(A) polymerase reveals terminal RNA methylation as a protective antiviral mechanismSimone Backes, Jillian S Shapiro, Leah R Sabin, et al.

AIDS Research and Human Retroviruses|July 10, 2004

Multiprotein HIV type 1 clade B DNA and MVA vaccines: construction, expression, and immunogenicity in rodents of the MVA componentLinda S Wyatt, Patricia L Earl, Jin Yan Liu, et al.

Vaccine|December 25, 2007

Correlation of immunogenicities and in vitro expression levels of recombinant modified vaccinia virus Ankara HIV vaccinesLinda S Wyatt, Patricia L Earl, Jennifer Vogt, et al.

Pageof 31